Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2022/10/13/2533469/0/en/ObsEva-Announces-IND-Approval-for-Yuyuan-Bioscience-s-Phase-1-Clinical-Trial-of-Nolasiban-in-China.html

GLOBENEWSWIRE
13 Oct 2022